Schedule 13G ownership disclosure

Ceribell Inc

Common Stock, $0.001 par value per share · CUSIP: 15678C102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ABG WTT-Ceribell Limited

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG V-Ceribell Limited

    Shares: 2,441,267.00 · Class: 6.8%

  • Ally Bridge Group Global Life Science Capital Partners V, L.P.

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG Global Life Science Capital Partners V GP, L.P.

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG Global Life Science Capital Partners V GP Limited

    Shares: 2,441,267.00 · Class: 6.8%

  • Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG-WTT Global Life Science Capital Partners GP, L.P.

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG-WTT Global Life Science Capital Partners GP Limited

    Shares: 2,441,267.00 · Class: 6.8%

  • ABG Management Ltd.

    Shares: 2,441,267.00 · Class: 6.8%

  • Ally Bridge Group (PE) LLC

    Shares: 2,441,267.00 · Class: 6.8%

  • Fan Yu

    Shares: 2,441,267.00 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-002726
Form type
SCHEDULE 13G
Filer
ABG Management Ltd.
CIK
CIK 1832106
Filed
May 02, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub